Evidence map›Paper›PMID 35687240›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2022

Implementing Multi-Enzyme Biocatalytic Systems Using Nanoparticle Scaffolds.

Joyce C Breger, Gregory A Ellis, Scott A Walper, Kimihiro Susumu, Igor L Medintz

Abstract read
PubMed Publisher
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.5field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Joyce C BregerCenter for Bio/Molecular Science and Engineering, Code 6900, Washington, DC, USA.
Gregory A EllisCenter for Bio/Molecular Science and Engineering, Code 6900, Washington, DC, USA.
Scott A WalperCenter for Bio/Molecular Science and Engineering, Code 6900, Washington, DC, USA.
Kimihiro SusumuOptical Sciences Division, Code 5611, U.S. Naval Research Laboratory, Washington, DC, USA.
Igor L MedintzCenter for Bio/Molecular Science and Engineering, Code 6900, Washington, DC, USA. Igor.medintz@nrl.navy.mil.
Center for Molecular Medicine and Immunology · USNaval Research Laboratory Center for Bio/Molecular Science and EngineeringOptical Sciences (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Interest in multi-enzyme synthesis outside of cells (in vitro) is becoming far more prevalent as the field of cell-free synthetic biology grows exponentially. Such synthesis would allow for complex chemical transformations based on the exquisite specificity of enzymes in a "greener" manner as compared to organic chemical transformations. Here, we describe how nanoparticles, and in this specific case-semiconductor quantum dots, can be used to both stabilize enzymes and further allow them to self-assemble into nanocomplexes that facilitate high-efficiency channeling phenomena. Pertinent protocol information is provided on enzyme expression, choice of nanoparticulate material, confirmation of enzyme attachment to nanoparticles, assay format and tracking, data analysis, and optimization of assay formats to draw the best analytical information from the underlying processes.

Indexed as

NanoparticlesQuantum DotsBiocatalysisKineticsAssayCascadeCatalysisEnzymeKineticsMichaelis–MentenMulti-EnzymeNanoparticleQuantum dotSpectrophotometrySynthetic Biology

Identifiers

PMID35687240
OpenAlexW4285164719

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.